Analyst ratings, especially from reputable firms like Baird, can significantly influence investor perception and stock prices. An Outperform rating coupled with a high price target suggests Baird's strong belief in Soleno Therapeutics' future performance, potentially leading to increased investor interest and a rise in stock price in the short term.